China Biotech Services Holdings Ltd. Provides Quarterly Update on Action Plan to Resolve Disclaimer of Opinion

Reuters

Jul 22

China Biotech Services Holdings Ltd. Provides Quarterly Update on Action Plan to Resolve Disclaimer of Opinion

China Biotech Services Holdings Ltd. has provided a quarterly update on the implementation of its action plan to address the disclaimer of opinion regarding going concern raised by its auditors for the year ended 31 December 2024. The company has made progress with its financing projects, which are expected to exceed RMB150 million in aggregate. Several projects are currently undergoing due diligence or awaiting internal approval by investors. The board continues to actively implement the action plan, aiming to resolve the disclaimer as soon as possible. Additionally, the management has successfully renewed a bank borrowing of RMB4,000,000, equivalent to approximately HK$4,388,000. Shareholders and potential investors are advised to exercise caution when dealing in the company's shares. Further updates on the implementation progress will be published as appropriate.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Biotech Services Holdings Ltd. published the original content used to generate this news brief on July 22, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2553259742"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2553259742\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2553259742?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-22 21:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2553259742","market":"us","top_or_hot":-1,"title":"China Biotech Services Holdings Ltd. Provides Quarterly Update on Action Plan to Resolve Disclaimer of Opinion","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      China Biotech Services Holdings Ltd. Provides Quarterly Update on Action Plan to Resolve Disclaimer of Opinion\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        China Biotech Services Holdings Ltd. has provided a quarterly update on the implementation of its action plan to address the disclaimer of opinion regarding going concern raised by its auditors for the year ended 31 December 2024. The company has made progress with its financing projects, which are expected to exceed RMB150 million in aggregate. Several projects are currently undergoing due diligence or awaiting internal approval by investors. The board continues to actively implement the action plan, aiming to resolve the disclaimer as soon as possible. Additionally, the management has successfully renewed a bank borrowing of RMB4,000,000, equivalent to approximately HK$4,388,000. Shareholders and potential investors are advised to exercise caution when dealing in the company's shares. Further updates on the implementation progress will be published as appropriate.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Biotech Services Holdings Ltd. published the original content used to generate this news brief on July 22, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Biotech Services Holdings Ltd. Provides Quarterly Update on Action Plan to Resolve Disclaimer of Opinion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Biotech Services Holdings Ltd. Provides Quarterly Update on Action Plan to Resolve Disclaimer of Opinion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-07-22 21:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      China Biotech Services Holdings Ltd. Provides Quarterly Update on Action Plan to Resolve Disclaimer of Opinion\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        China Biotech Services Holdings Ltd. has provided a quarterly update on the implementation of its action plan to address the disclaimer of opinion regarding going concern raised by its auditors for the year ended 31 December 2024. The company has made progress with its financing projects, which are expected to exceed RMB150 million in aggregate. Several projects are currently undergoing due diligence or awaiting internal approval by investors. The board continues to actively implement the action plan, aiming to resolve the disclaimer as soon as possible. Additionally, the management has successfully renewed a bank borrowing of RMB4,000,000, equivalent to approximately HK$4,388,000. Shareholders and potential investors are advised to exercise caution when dealing in the company's shares. Further updates on the implementation progress will be published as appropriate.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Biotech Services Holdings Ltd. published the original content used to generate this news brief on July 22, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1511","symbol_name":"疑似财技股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250722:nNDL9mF8wz:1","article_id":"2553259742","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2553259742","pubTimestamp":1753192581,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"China Biotech Services Holdings Ltd. has provided a quarterly update on the implementation of its action plan to address the disclaimer of opinion regarding going concern raised by its auditors for the year ended 31 December 2024. The company has made progress with its financing projects, which are expected to exceed RMB150 million in aggregate. Several projects are currently undergoing due diligence or awaiting internal approval by investors. The board continues to actively implement the action plan, aiming to resolve the disclaimer as soon as possible. Additionally, the management has successfully renewed a bank borrowing of RMB4,000,000, equivalent to approximately HK$4,388,000. Shareholders and potential investors are advised to exercise caution when dealing in the company's shares. Further updates on the implementation progress will be published as appropriate.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT striv","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1511":"疑似财技股","BK1219":"保健护理服务","08037":"中国生物科技服务"},"translate_title":"中国生物科技服务控股有限公司提供解决无法发表意见的行动计划季度更新","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"08037":0.9},"content_text":"China Biotech Services Holdings Ltd. Provides Quarterly Update on Action Plan to Resolve Disclaimer of Opinion\n    \n\n        China Biotech Services Holdings Ltd. has provided a quarterly update on the implementation of its action plan to address the disclaimer of opinion regarding going concern raised by its auditors for the year ended 31 December 2024. The company has made progress with its financing projects, which are expected to exceed RMB150 million in aggregate. Several projects are currently undergoing due diligence or awaiting internal approval by investors. The board continues to actively implement the action plan, aiming to resolve the disclaimer as soon as possible. Additionally, the management has successfully renewed a bank borrowing of RMB4,000,000, equivalent to approximately HK$4,388,000. Shareholders and potential investors are advised to exercise caution when dealing in the company's shares. Further updates on the implementation progress will be published as appropriate.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Biotech Services Holdings Ltd. published the original content used to generate this news brief on July 22, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}